Association between donor-recipient HLA-DR compatibility and cytomegalovirus hepatitis and chronic rejection in liver transplantation.
Mañez
R
R
Department of Pathology, University of Pittsburgh, School of Medicine, Pennsylvania.
White
L T
LT
Kusne
S
S
Martin
M
M
Demetris
A J
AJ
Starzl
T E
TE
Duquesnoy
R J
RJ
D000328:Adult; D003586:Cytomegalovirus Infections / Q000150:complications*; D006084:Graft Rejection / Q000276:immunology* / Q000473:pathology / Q000503:physiopathology; D006684:HLA-DR Antigens / Q000276:immunology*; D006505:Hepatitis / Q000150:complications* / Q000382:microbiology; D006650:Histocompatibility Testing; D006801:Humans; D016031:Liver Transplantation / Q000276:immunology* / Q000473:pathology; D016853:Muromonab-CD3 / Q000627:therapeutic use; D016559:Tacrolimus / Q000627:therapeutic use; D014019:Tissue Donors
D006684:HLA-DR Antigens; D016853:Muromonab-CD3; D016559:Tacrolimus